T H 17–Associated Polyamine Metabolism‐Guided Nanozyme Promotes Alveolar Bone Repair in Periodontitis
Advanced Science · 2026-11 · 13 (62)
DOI: 10.1002/advs.77247 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 18.08.2026. Verfasst von Cheng Zhu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthodontics, College of Stomatology, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Ni…. Hauptthemen laut MEDLINE: Th17 Cells, Periodontitis, Polyamines, Alveolar Bone Loss. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, PhD Cultivation Fund for Science and Innovation of Shanghai Jiao Tong University School of Medicine.
Abstract (Originalsprache)
Periodontitis is a chronic inflammatory disease characterized by persistent inflammation and limited repair at sites of alveolar bone loss. Although excessive reactive oxygen species (ROS) are recognized drivers of periodontal tissue damage, oxidative stress alone does not fully explain the persistence of inflammation and the failure of regeneration. The immune and metabolic processes that cooperate with oxidative stress in sustaining this disease‐supporting microenvironment remain incompletely defined. In this study, a pronounced T H 17‐skewed CD4 + T cell response is identified in experimental periodontitis, and enrichment of polyamine pathway activation is observed during T H 17 differentiation, suggesting a candidate immunometabolic axis for intervention. Guided by this observation, difluoromethylornithine‐loaded UiO‐66(Ce)‐Mn (DFMO@Ui‐Mn) is developed as a nanozyme platform that integrates the cascade ROS‐scavenging activity of UiO‐66(Ce)‐Mn with DFMO delivery for inhibition of polyamine metabolism. DFMO@Ui‐Mn reduces T H 17 polarization in vitro, alters polyamine‐related metabolic profiles, attenuates inflammatory responses in vivo, lowers the T H 17/Treg ratio, improves osteogenic readouts in a conditioned‐medium model, and promotes alveolar bone repair in ligature‐induced periodontitis. These findings support a therapeutic strategy that combines redox control with immunometabolic intervention to improve the periodontal microenvironment under inflammatory conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthodontics, College of Stomatology, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicin…
- School of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing, China.
ORCID-Profile: Tiancheng Li, Qicheng Liu, Jin Hao, Bing Fang, Lunguo Xia
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- PhD Cultivation Fund for Science and Innovation of Shanghai Jiao Tong University School of Medicine
Zitieren
APA
Zhu, C., Li, T., Jin, Y., Li, Y., Liu, Q., Fang, R., Qu, L., Tang, X., Li, R., Zhao, X., Hao, J., Fang, B., & Xia, L. (2026). T H 17–Associated Polyamine Metabolism‐Guided Nanozyme Promotes Alveolar Bone Repair in Periodontitis. Advanced Science, 13(62). https://doi.org/10.1002/advs.77247
Vancouver
Zhu C, Li T, Jin Y, Li Y, Liu Q, Fang R, et al. T H 17–Associated Polyamine Metabolism‐Guided Nanozyme Promotes Alveolar Bone Repair in Periodontitis. Advanced Science. 2026;13(62). doi:10.1002/advs.77247
BibTeX
@article{Zhu2026,
author = {Zhu, Cheng and Li, Tiancheng and Jin, Yu and Li, Yixin and Liu, Qicheng and Fang, Runzhe and Qu, Luyao and Tang, Xinyue and Li, Ruomei and Zhao, Xiaoyue and Hao, Jin and Fang, Bing and Xia, Lunguo},
title = {T H 17–Associated Polyamine Metabolism‐Guided Nanozyme Promotes Alveolar Bone Repair in Periodontitis},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {62},
doi = {10.1002/advs.77247}
}
EUVIMED